Abstract

The central melanocortin system plays a fundamental role in the control of feeding and body weight. Proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus (ARC) also regulate overall glucose homeostasis via insulin-dependent and -independent pathways. Here, we report that a subset of ARC POMC neurons innervate the liver via preganglionic parasympathetic acetylcholine (ACh) neurons in the dorsal motor nucleus of the vagus (DMV). Optogenetic stimulation of this liver-projecting melanocortinergic pathway elevates blood glucose levels that is associated with increased expression of hepatic gluconeogenic enzymes in female and male mice. Pharmacological blockade and knockdown of the melanocortin-4 receptor gene in the DMV abolish this stimulation-induced effect. Activation of melanocortin-4 receptors inhibits DMV cholinergic neurons and optogenetic inhibition of liver-projecting parasympathetic cholinergic fibers increases blood glucose levels. This elevated blood glucose is not due to altered pancreatic hormone release. Interestingly, insulin-induced hypoglycemia increases ARC POMC neuron activity. Hence, this liver-projecting melanocortinergic circuit that we identified may play a critical role in the counterregulatory response to hypoglycemia.

Hypothalamic melanocortin neurons regulate systemic glucose homeostasis through incompletely understood pathways. Here, the authors show that a subset of pro-opiomelanocortin neurons innervate the liver via preganglionic parasympathetic cholinergic neurons in the dorsal motor nucleus of the vagus and that stimulation of this pathway elevates blood glucose levels

Details

Title
Optogenetic stimulation of the liver-projecting melanocortinergic pathway promotes hepatic glucose production
Author
Kwon Eunjin 1   VIAFID ORCID Logo  ; Hye-Young, Joung 1   VIAFID ORCID Logo  ; Shun-Mei, Liu 1 ; Chua, Streamson C, Jr 1 ; Schwartz, Gary J 1   VIAFID ORCID Logo  ; Young-Hwan, Jo 2   VIAFID ORCID Logo 

 Albert Einstein College of Medicine, The Fleischer Institute for Diabetes and Metabolism, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997); Albert Einstein College of Medicine, Division of Endocrinology, Department of Medicine, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997) 
 Albert Einstein College of Medicine, The Fleischer Institute for Diabetes and Metabolism, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997); Albert Einstein College of Medicine, Division of Endocrinology, Department of Medicine, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997); Albert Einstein College of Medicine, Department of Molecular Pharmacology, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2473210851
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.